Produktbild: Plasma Fractionation and Blood Transfusion
Band 13

Plasma Fractionation and Blood Transfusion Proceedings of the Ninth Annual Symposium on Blood Transfusion, Groningen, 1984, organized by the Red Cross Blood Bank Groningen-Drenthe

Fr. 72.90

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

04.10.2011

Abbildungen

250 p.

Herausgeber

C.Th. Smit Sibinga + weitere

Verlag

Springer Us

Seitenzahl

250

Maße (L/B/H)

23.5/15.5/1.5 cm

Gewicht

400 g

Auflage

Softcover reprint of the original 1st ed. 1985

Sprache

Englisch

ISBN

978-1-4612-9644-7

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

04.10.2011

Abbildungen

250 p.

Herausgeber

Verlag

Springer Us

Seitenzahl

250

Maße (L/B/H)

23.5/15.5/1.5 cm

Gewicht

400 g

Auflage

Softcover reprint of the original 1st ed. 1985

Sprache

Englisch

ISBN

978-1-4612-9644-7

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: ProductSafety@springernature.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Plasma Fractionation and Blood Transfusion
  • I. Source material.- The future blood supply system in the USA: A prognosis.- Plasma supply. National and international logistics, whole blood versus plasmapheresis.- Processing criteria for recovery of FFP for fractionation.- Donation procedure: Collection lesion, fibrinopeptide A, and factor VIII.- Discussion.- II. Technology of plasma fractionation.- Small pool versus large pool in plasma fractionation: Reevaluation of a concept.- Ethanol fractionation of human plasma: An overview.- Control of large-scale plasma thawing.- Contributions to the optimization of factor VIII production: Cryoprecipitation and controlled pore glass adsorption.- Chromatographic methods of plasma fractionation.- Polyelectrolyte fractionation technology.- Recombinant DNA technology for the production of plasma proteins.- Column ion exchange chromatographic production of albumin, IV ISG and factor IX from 75,000 to 100,000 litres of plasma per year.- Large scale chromatographic experiments for plasma fractionation.- Discussion.- III. Safety aspects.- Preservation of structure and function during isolation of human plasma proteins.- The impact of donor selection of virus transmission.- Prevention of transmission of virus infections by blood transfusions and removal of virus infectivity from clotting factor concentrates.- Inactivation of hepatitis viruses (B, non-A/non-B) and retroviruses in pooled human plasma by means of ?-propiolactone-and UV-treatment.- HTLV-I/II and HTLV-III seroprevalence in blood product recipients.- Sero-epidemiology of the human T-lymphotropic retroviruses HTVL-I and HTLV-III in the Netherlands.- Discussion.- IV. Clinical aspects.- Needs, quality versus quantity.- Clinical characteristics of the factor VIII protein from various factor VIII concentrates.- Clinical use ofpolyelectrolyte-fractionated porcine factor VIII.- Factor VIII:C assay standardisation.- The current of status of fibronectin in clinical medical practice.- Intravenous use of gammaglobulin in 1984.- Discussion.